In this study, we tested the hypothesis suggesting that the presence of albuminuria reflects impaired aortic elastic properties in type 2 DM.Methods: Overall 140 patients with type 2 DM without obvious renal impairment (serum creatinine
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: Albuminuria is a predictor of cardiovascular morbidity and mortality in patients with diabetes (DM).
📊
Key Findings & Data:Objective: Albuminuria is a predictor of cardiovascular morbidity and mortality in patients with diabetes (DM).
💡
Conclusion & Impact:In this study, we tested the hypothesis suggesting that the presence of albuminuria reflects impaired aortic elastic properties in type 2 DM.Methods: Overall 140 patients with type 2 DM without obvious renal impairment (serum creatinine
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Objective: Albuminuria is a predictor of cardiovascular morbidity and mortality in patients with diabetes (DM). In this study, we tested the hypothesis suggesting that the presence of albuminuria reflects impaired aortic elastic properties in type 2 DM.Methods: Overall 140 patients with type 2 DM without obvious renal impairment (serum creatinine
Özet
Amaç: Albuminüri diyabetes mellitus (DM)’lu hastalarda kardiyovasküler mortalite ve morbiditenin öngördürücüsüdür. Bu çalışmada, Tip 2 diyabetes mellitusta albüminüri gelişmesinin aortik elastisitede bozulmayı yansıtabileceği hipotezini test ettik.Yöntemler: Çalışmaya aşikar böbrek yetersizliği olmayan (serum kreatinin
🔖
Cite This Article
DEMİRTUNÇ, R., KARATAŞ, M., DUMAN, D., KARADAĞ, B. (2022). Tip 2 diyabetes mellitusta albüminürinin, aortik elastisite ve sol ventrikül diyastolik fonksiyonu ile ilişkisi. Anadolu Kardiyoloji Dergisi, Cilt: 8 - Sayı: 1, 10–15. https://ajindex.com/articles/437013
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-9
Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, et al. HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.JAMA 2001;286:421-6. 4. de Zeeuw D, Remuzzi G, Parving H-H, Keane WF, Zhang Z, Shahinfar S, et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 2004; 110: 921 -7
Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Arch Intern Med 1997; 157: 1413-8
Mogensen CE. Microalbuminuria, blood pressure and diabetic renal disease: Origin and development of ideas. Diabetologia 1999; 42: 263-85
Stehouwer CD, Nauta JJ, Zeldenrust GC, Hackeng WH, Donker AJ, den Ottolander GJ. Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 1992; 340: 319-23
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: An integrated index of vascular function? Circulation 2002; 106: 2085-90
Morgensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-60
Mattock MB, Morrish NJ, Viberti G, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992; 42: 736-41
Mattock MB, Barnes DJ, Viberti GC, Keen H, Burt D, Hughes JM, et al. Microalbuminuria and coronary heart disease in NIDDM. Diabetes 1998;47:1786-92
Cosson S, Kevorkian JP. Left ventricular diastolic dysfunction: an early sign of diabetic cardiomyopathy ? Diabetes Metab 2003; 29: 455-66
Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glu